期刊文献+

幽门螺旋杆菌感染与特发性血小板减少性紫癜相关性研究 被引量:1

Research on relationship between H.pylori infection and idiopathic thrombocytopenic purpura
下载PDF
导出
摘要 目的探讨幽门螺旋杆菌(HP)在特发性血小板减少性紫癜(ITP)发病中的意义,观察对ITP患者抗HP治疗的疗效。方法对138例ITP患者进行HP检测,阳性患者81例随机分为A、B两组,A组(42例)给予糖皮质激素及抗HP治疗;B组(39例)单用糖皮质激素治疗,观察两组疗效。结果 138例ITP患者中HP阳性者81例,阳性率58.7%;A组42例患者中治疗有效37例(88%),B组39例患者中治疗有效30例(76.9%),两组差异有统计学意义(P<0.05);两年内复发率A组21.3%,B组43.5%,差异有统计学意义(P<0.01)。A组中急性ITP17例,总有效率82%,慢性ITP25例,总有效率92%,差异有统计学意义(P<0.05)。结论 HP感染与部分ITP的发病密切相关,加用抗HP治疗可提高ITP疗效,降低复发率,尤其对慢性血小板减少性紫瘢(CITP)患者效果更好。 Objective To explore the significance of Helicobacter pylori infection in patients with idiopathic thrombocytopenic purpura(ITP)and observe the effect of HP eradication on the therapeutic efficacy of ITP patient.Methods 138 ITP patients were screened for Hp infection.ITP patients with Hp-positive were randomly divided into 2 groups(group A and group B).The group A(n=42) received glucocorticoid and Hp eradication.The group B(n=39) received only glucocorticoid.The clinical efficacy was evaluated.Results Among the 138 ITP patients,81 patients(58.7%) were complicated with Hp infection.The effective rate in group A(88%) was significantly higher than that(75%) in group B(P〈0.05).The recurrence rate in 2 years in group A(21.3%) was significantly lower than that(43.5%) in group B(P〈0.01).Of all the 42 patients of group A,17 patients were diagnosed with acute IPT(AITP) with effective rate of 92%,and another 25 patients were diagnosed with chronic ITP(CITP) with effective rate of 92%.There were significant differences between two groups(P〈0.05).Conclusion Hp infection is closely relevant to part of ITP.Hp eradication in ITP patients with Hp-positive can improve efficacy and reduce the recurrence,especially for the CITP patients.
出处 《西部医学》 2012年第10期1969-1970,1973,共3页 Medical Journal of West China
关键词 幽门螺杆菌 特发性血小板减少性紫癜 相关性 Helicobacter pylori Idiopathi thrombocytopenic purpura
  • 相关文献

参考文献5

  • 1TaKab.ashi T, Yujiri T, Shinohara K, et al. Molecular mimicry by Helicobacter Pylori CagA protein may be involved in the path- ogenesis of H. Pylori-associated chronic immune thromboeytope- nie purpura[J]. Br J Haematol, 2004, 124: 91-96.
  • 2Bai Y, Wang Z, Bai X, et al. Cross-reaction of antibody against Helicobacter Pylori urease B with platelet glycoprotein m a and itssignificance in the pathogenesis of immune thrombocytopenic pur- pura[J]. Int J Hematol, 2009, 89 : 142-149.
  • 3Asahi A, Kuwana M, Suzuki H, et al. Effects of a Helicobacter Pylori eradication regimen on anti-platelet autoantibody response in infected and uninfected patients with idiopathic thrombocytope- nie purpura[J]. Haematologica, 2006, 91 :1426-1437.
  • 4Kahda K, Andreu R, L Lopis I, et al. Absence of platelet re- sponse after eradication of Helicobacter Pylori infection in pa- tients with chronic idiopathic thrombocytopenic purpura[J]. Br J Haematology, 2001, 115(4),1002-1003.
  • 5王兆钺.免疫性血小板减少性紫癜的发病机制与临床研究进展[J].中国免疫学杂志,2009,25(12):1141-1144. 被引量:30

二级参考文献24

  • 1Rodeghiero F, Stasi R, Gemsheimer T et al. Standardization of terminology,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group [ J ]. Blood,2009; 113( 11 ) :2386-2393.
  • 2Beardsley DS. ITP in the 21^st century[ J]. Hematology,2006; 1:402-407.
  • 3Wu C L, Xu J C, Li F etal. Polarization and apoptosis of T cell subsets in idiopathic thrombocytopenic purpura[ J ]. Int J Lab Hematol, 2007 ; 29 (3) : 177-184.
  • 4Zhang F, Chu X,Hou Met al. Cell-mediated lysis of autologous platelets in chronic diopathic thrombocytopenic purpura[J]. Eur J Haematol,.2006; 76: 427-431.
  • 5Webster M L, Sayeh E, Crow Met al. Relative efficacy of intravenous immunoglobulin G in ameliorating thrombocytopenia induced by antiplatelet GP Ⅱ b Ⅲ a versus GP I b antibodies[ J ]. Blood, 2006; 108 (3) :943-946.
  • 6George J N,Woolf S H, Raskob G E et al. Idiopathic thrombocytopenic puiptwa: a practice guideline developed by explicit methods for the American Society of Hematology [ J ]. Blood, 1996; 88 ( 1 ) : 3-40.
  • 7Fabris F, Scandellari R, Ruzzon E et al. Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpum[ J]. Blood, 2004; 103(12) :4562-4564.
  • 8Cines D B, McMillan R. Management of adult idiopathic thrombocytopenic purpura[J]. Annu Rev Med,2005;56:425-d42.
  • 9Provan D,Newland A,Bolton-Maggs Pet al. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy[ J]. Br J Haematol,2003; 120(4) :574-596.
  • 10Borst F, Keuning J J, van Hulsteijn H etal. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults[ J ]. Ann Hematol, 2004; 83 ( 12 ) : 764-768.

共引文献29

同被引文献16

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部